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Introduction
Neoplasms arising from glial cells, called gliomas, are
the most common brain tumours, accounting for over
50% of all brain neoplasms [1]. Although their biolo-
gy has been known, these tumours still have excep-
tionally unfavourable prognosis.
In 1971, J. Folkman hypothesized that the growth
of solid tumours is angiogenesis-dependent and that
therapeutic actions undertaken to inhibit this process
are a likely antineoplastic therapy [1-5]. This also
refers to brain gliomas.
Brain gliomas are characterized by invasive growth
and neovascularisation potential. Angiogenesis is a
basic mechanism allowing tumour growth [4,6].
Increased neoplastic proliferation of glial cells runs
parallel to endothelial vascular proliferation, which
apart from cell atypia and necrosis, is one of the malig-
nancy evaluation criteria. Depending on tumour's his-
tological type and malignancy grade, angiogenesis
exhibits varied intensity [7,8]. Highly malignant
tumours show markedly pronounced proliferation of
vascular endothelial cells, increasing tumour vascula-
ture [9]. In the microscopic picture, proliferating ves-
sels assume the forms from fine capillaries to well-
developed glomerular structures [10].
Tumour vessels form two populations. One consists
of physiologically existing intratumoral vessels, the
other includes capillaries formed via angiogenesis in
response to angiogenic factors [11].
In recent years, it has been demonstrated that
angiogenesis has a great role in glioma progression
and its determination is one of the major prognostic
factors [12-15].
The aim of the study was to assess vascularisation
of chosen brain gliomas and to find correlations
between vascularisation and histological type of the
neoplasms, its malignancy grade, location, size and
age and gender of patients. The angiogenic potential in
gliomas was analysed according to the morphology of
microvascular proliferation and by assessment of the
vascular density.
Materials and methods
Patients. Ninety-nine patients (54 women and 45 men) aged 18-80
years with clinically diagnosed brain tumour were included in the
study. Based on histopathological investigations performed to
determine tumour's histological type and malignancy grade, the
patients were divided into study groups according to the WHO
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classification [16]. Group I consisted of patients with astrocytoma
(22 patients, mean age 43.18), group II - patients with anaplastic
astrocytoma (31 patients, mean age 55.84), group III - patients with
multiform glioblastoma (23 patients, mean age 62.04), group IV -
patients with oligodendroglioma (12 patients, mean age 44.5) and
group V had patients with anaplastic oligodendroglioma (11
patients, mean age 54.64) (Table 1).
Imaging diagnostics. CT and/or MRI were performed in all the
patients prior to surgery to determine tumour size and location
(left/right hemisphere, frontal lobe, parietal lobe, temporal lobe,
sensory-locomotor region and posterior contact region) (Table 1).
Histopathological examination. In each patient, intraoperative
examination was performed to obtain preliminary diagnosis and to
establish the extent of surgical procedure. Material for intraopera-
tive analysis was routinely embedded in gel (Tissue Freezing
Medium Jung) at a temperature  of approximately minus 24°C, and
stained with haematoxylin and eosin (HE).
After the preliminary diagnosis had been made, two speci-
mens, approx. 10 mm × 10 mm × 1 mm, were obtained from the
tumour tissue (when the amount of the material was too small, it
was stored for further analysis) and fixed for 24 h in 10% buffered
formalin solution at room temperature. After dehydration in alco-
hol series and xylene, the specimens were embedded in paraffin of
temperature 55°C.
Material storage procedure allowed preservation of antigen
structures and appropriate performance of immunohistochemical
investigations.
Paraffin sections, 5 μm thick, were cut from paraffin blocks on
a sledge microtome and placed on sialinized glass slides. In each
case, HE staining was performed. Using the microscopic picture,
final diagnosis was made of histological type and malignancy
grade.
Immunohistochemical investigations, angiogenesis. Tumour
vascularisation analysis was based on the determination of
microvascular proliferation (MVP) and microvessel density
(MVD).
Microvascular proliferation  was measured with immunohisto-
chemical methods using mouse monoclonal antibodies to detect
cell proliferation antigens. The following antibodies were used: Ki-
67 (clone MIB-1, dilution 1:50, catalogue no M7240, DAKO) and
PCNA (clone PC 10, dilution 1:100, catalogue no. M0879,
DAKO). The specimens were prepared for immunohistochemical
analysis with the methods recommended by the producer (DAKO).
For vessel visualization, the following antibodies were used
against endothelial cell antigens: CD31 antibody (clone JC/70A,
dilution 1:20, catalogue no M 0823, DAKO) and anti-von Wille-
brand factor (clone F8/86, dilution 1:25, catalogue no M 0616,
DAKO). Assimakopoulou and Korkolopoulou used the same
antibodies for vessel identification [13,17]. Microvascular prolif-
eration was defined by determining the proliferation index (PI of
MVP), which expressed the percentage of cells with positive
nuclear reaction for Ki-67 and PCNA in comparison to the total
number of  endothelial cells examined. The antigen-antibody
reaction intensity was assessed in the scale: /-/ lack of reaction,
/+/ weak reaction - slightly brown colour of the nuclei, /++/
medium reaction - brown-dark brown colour of the nuclei, /+++/
intensive reaction - strongly brown colour of the nuclei. The pro-
liferation index in each case was the average score of the prolif-
eration indices of four microscopic fields at magnification of
400×. Vessel density was estimated as the number of vessels per
1 mm2.
Morphometric programme Microlmage InCD UDF Packed
Writing Software for Windows (Olympus) was used for the assess-
ment of angiogenesis.
Statistical analysis. Statistica PL programme with Stat Soft test
was used for statistical analysis of the results. For comparison of
means, t-student's test was performed.
Ethical issues. The study was approved by the Bioethical Com-
mittee of the Medical University of Bialystok (R-I-003/182/2006).
Results
The highest proliferative activity of endothelial cells
was found in multiform glioblastoma (Fig. 1). The
average value of Ki-67 PI of MVP was 22.93 while
PCNA PI of MVP - 29.33. The lowest mean values of
PI of MVP of endothelial cells were observed in the
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Table 1. Microvascular proliferation, microvessel density, diameter et location of tumors in the respective study groups. 
PI - proliferation index, MVP - microvascular proliferation, MVD - microvessel density, x - mean, SD - standard deviation.
texture of oligodendrogliomas (Ki-67 PI of MVP-1.11,
PCNA PI of MVP-1.53, Fig. 2).
All types of tumours exhibited simple vascular pro-
liferation type. Enhanced glomerular proliferation type
was found only in patients with multiform glioblas-
toma (group III, in  65.2% patients), assuming the
form of single structures in 30.43% patients, numerous
vascular groups in 26.08% and conglomerates in
8.69% patients. The highest vessel density was noted
in elderly patients over 65 years of age. Only in  these
patients, glomerular conglomerates and numerous vas-
cular groups were found.
The highest microvascular density (MVD) was
revealed in multiform glioblastoma (mean 31.5 ves-
sels/mm2), the lowest in oligodendroglioma (6.75 ves-
sels/mm2).
In our study, anaplastic astrocytomas had the
largest diameter (mean 5.27 ± 1.5 cm). Slightly small-
er were astrocytomas (mean 4.96 ± 0.98 cm) and
anaplastic oligodendrogliomas (mean 3.63 ± 1.07 cm).
In astrocytoma patients, the most frequent tumour
location was the temporal lobe (40.9%),  the least - the
parietal lobe (9.1%). The most common site of
anaplastic astrocytoma was the frontal lobe (32.3%)
and the temporal lobe (25.8%).
Multiform glioblastoma was most frequently found
in the temporal lobe (43.5%), least frequently in the
sensory-locomotor region (8.7%).
The most common site of oligodendrogliomas, like in
the case of anaplastic astrocytomas, was the frontal lobe
(50%). Detailed data have been presented in Table 1.
Discussion
The values PI of MVP were varied and determined by
tumour malignancy grade. The highest PI of MVP was
found in multiform glioblastoma (mean 29.33 PCNA
PI of MVP and 22.93  Ki-67 PI of MVP). In the study
conducted by Kern the values were lower (mean 9.4
for Ki-67) [8]. The values of PI of MVP were the low-
est in oligodendrogliomas and did not differ much in
the respective fields of the same tumour. The prolifer-
ative activity of endothelial cells was considerably
intensified in anaplastic oligodendrogliomas, and in
these neoplasms PI values differed more often between
the respective fields.
In astrocytoma patients, PI of MVP values were
lower compared to those noted in patients with
anaplastic astrocytoma. Our results indicate that
gliomas of higher malignancy grade show more inten-
sified proliferation activity of vascular endothelial
cells. This activity is also more varied in the respective
fields of the same tumour.
The highest microvascular density (MVD) indicat-
ing tumour vascularisation was observed in multiform
glioblastoma (from 16 to 52; ± 31.5), the lowest in
oligodendroglioma (from 3 to 11; ± 6.75). Assi-
makopoulou described similar relations in vascularisa-
tion in the respective histological types of brain
tumours [17]. However, compared to the data reported
by I¿ycka, the scores for multiform glioblastoma are
lower [18]. Vascular density in multiform glioblastoma
is markedly higher than in tumours of lower histologi-
cal grade [1]. Gupta also found a statistically signifi-
cant correlation between vascular proliferation and
tumour malignancy grade [19].
Angiogenesis has been known as a factor determin-
ing tumour growth rate and a potential relapse. Studies
on gliomas have revealed an inverse correlation
between vascular density and survival time. An
increase in vascularisation significantly worsens prog-
nosis. Thus, measurement of vascular density in
tumour tissue can be an accessory prognostic factor in
patients with brain tumours [8,9,12,14,17]. This has
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Fig. 1. Multiform glioblastma. Endothelial cells with immunohis-
tochemical reaction of  Ki-67 (magnification × 400).
Fig. 2. Oligodendroglioma. Endothelial cells with immunohisto-
chemical reaction of PCNA (magnification × 400).
been reported, among others, by Leon and Kern,
although they found no significant differences in vas-
cularisation between primary and recurrent multiform
glioblastoma [8,14].
In our study, most blood vessels were situated in
the tumour peripheral part. These observations are
consistent with the data published by Wojtukiewicz
[15]. Endothelial cells of the vessels lying on tumour
periphery showed stronger reactions to CD31 antibod-
ies and anti-factor VIII antibody.
The present analysis revealed a positive correlation
between tumour diameter and proliferative activity of
endothelial cells in the group of patients with astrocy-
toma and multiform glioblastoma, but not in the other
groups.
In patients with brain gliomas, tumour location is of
greater clinical value than its size. No significant dif-
ference was found in location depending on the hemi-
sphere in any of the groups. No correlation was found
between glioma location and MVP or MVD. In the
current study, the incidence of brain tumour was high-
er in women. Only in the anaplastic astrocytoma
group, men prevailed. No differences in age were
observed between women and men.
In most cases, there was no correlation between age
and tumour vascularisation. Only in patients with mul-
tiform glioblastoma over 65 years, vessel density was
higher. I¿ycka described a negative correlation
between tumour vascularisation and patients' age.
Patients' age has been also found to influence the rate
of relapses of brain tumours [18]. 
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